Second World Summit on Cancer Heterogeneity and Precision Medicine Meets in Washington
Second World Summit on Cancer Heterogeneity and Precision Medicine Meets in Washington
Topics: Cancer Heterogeneity, Liquid biopsy, CTCs, FFPE, International experts, International conference, Menarini International Foundation, Precision Medicine
Products Optimized for Targeted Resequencing and Exome Sequencing of FFPE Cells
Topics: FFPE, NGS, target sequencing, exome sequencing
Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company that is part of the pharmaceutical Menarini Group, presented recent findings obtained with its breakthrough state-of-the-art DEPArray™ technology in the characterization of pure tumor cell subpopulations derived from formalin fixed paraffin embedded (FFPE) tissue samples at the European Association of Cancer Research Meeting in Florence (June 20-23).
DEPArray™ technology resolves heterogeneity in solid tumors by digitally sorting 100% pure subpopulations of cells from FFPE samples, thus allowing differential analysis and characterization of tumor vs stromal cell populations resulting in unprecedented data in the subsequent Next Generation Sequencing (NGS) analysis.
Topics: FFPE
